# PAROLA (NCT05581121)

> PARa-aOrtic LymphAdenectomy in Locally Advanced Cervical Cancer

No report yet. It can be ordered.

- Drugs tested: none (the trial tests a strategy, not a drug)
- Indication: locally advanced cervical cancer

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT05581121
- Phase: PHASE3
- Status: RECRUITING
- Sponsor: Institut Claudius Regaud
- Conditions: Cervical Carcinoma; Adenocarcinoma; Adenosquamous Carcinoma
- Interventions: Standard treatment: Control arm; Experimental arm
- Enrollment: 510
- Primary outcome: Disease Free Survival (DFS)

## Indexed commentary on PAROLA so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- 2 YouTube videos
- 1 post on X

## Order

Focused, $750 at most (a smaller delivered size costs its own price): https://www.erudio.com/contact?report=parola-nct05581121
